Bill S-201: what Canada’s proposed sickle cell framework covers, and where it stands

Bill S-201, the National Framework on Sickle Cell Disease Act, would require the federal Minister of Health to develop a national framework on sickle cell disease. It passed the Senate on November 18, 2025, and cleared second reading in the House of Commons on June 16, 2026. As of October 2026, it is at committee stage in the House, with report stage, third reading and Royal Assent still ahead.

More than 6,000 people in Canada live with sickle cell disease, a figure cited by both NotJustYou and Canadian Blood Services. Health care is delivered by each province and territory, and there is no national plan for sickle cell today. Bill S-201 would require one.

What Bill S-201 is

Bill S-201 is a Senate public bill sponsored by Senator Marie-Françoise Mégie. It was introduced on May 28, 2025, in the first session of the 45th Parliament.

The bill does not create services on its own. It requires the Minister of Health to develop a framework in consultation with other federal ministers, provincial and territorial governments, and stakeholders such as people living with sickle cell, caregivers, service providers, and medical and research representatives. Within one year of the law coming into force, the Minister would table a report in Parliament setting out the framework, followed within three years by a report on which measures are in place and how well they work.

Earlier bills on the same subject never became law. LEGISinfo lists several, most recently Bill S-280 in the previous Parliament, which stopped after second reading in the Senate. Bill S-201 has already gone further than any of them.

What the framework would address

The bill names nine areas the framework must include. In plain terms, they are:

• Universal newborn screening, diagnosis after birth when needed, and results provided to families
• Training and education for health care professionals, and the diagnostic and treatment tools they need
• Evidence-based national standards for diagnosis and treatment
• A national research network, better data collection and a national registry
• An analysis of covering essential treatments under public drug insurance plans
• Including sickle cell disease in the eligibility criteria for existing disability benefits
• An analysis of a tax credit for people living with sickle cell and their caregivers
• Public awareness campaigns about sickle cell disease and blood donation
• Measures to promote blood donation in every community and a diverse blood supply for safe transfusions

None of this is law yet. If the bill passes, the details would take shape through the consultations it requires, and Parliament would see the result in the Minister’s first report.

Where the bill stands

• May 28, 2025: introduced in the Senate (first reading)
• October 23, 2025: a Senate committee reported the bill without amendment
• November 18, 2025: passed third reading in the Senate
• December 11, 2025: first reading in the House of Commons
• April 17, 2026: second reading debate began in the House
• June 16, 2026: passed second reading and was referred to the House of Commons Standing Committee on Health
• October 2026: at committee stage in the House, with no Royal Assent yet

LEGISinfo shows no committee meetings on the bill so far. At committee stage, MPs can hear from witnesses, study the bill clause by clause and propose amendments before reporting it back to the House.

What happens next

After the committee reports, the bill returns to the House for report stage and third reading. A bill must pass both Houses in identical form, so any amendments made by MPs would need the Senate’s agreement. Only then can the bill receive Royal Assent and become law.

Timing depends on when the committee schedules its study. Steady, respectful contact from constituents helps keep the bill on MPs’ radar.

Why it matters to families

Sickle cell is an inherited red blood cell disorder, and its effects reach from the delivery room to the emergency room to the workplace. The framework touches each of those places.

In April, a Cells peer support session took on a question many warriors recognize: “Is My Doctor Even Listening?” National standards for diagnosis and treatment, and better training for health professionals, speak directly to that experience.

Pain crises and hospital stays can interrupt school and work for warriors and caregivers alike. Including sickle cell in disability benefit criteria, and studying a tax credit, would recognize that cost. A diverse blood supply matters too, because people living with sickle cell often rely on blood from donors of similar ancestry.

How to add your voice

A personal letter is one of the simplest ways to put sickle cell on your MP’s desk. NotJustYou built a letter tool at bills-201.ca to make it quick: personalize the letter, choose your Member of Parliament and send it.

Ask your MP to support Bill S-201 and to help it move through committee. If you live with sickle cell or care for someone who does, a line or two about your own experience gives the letter weight.

You do not need a diagnosis to write. Caregivers, sickle supporters, health workers and neighbours can all ask their MP to support the bill.